Introduction
============

Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, accounting for more than 1 million cases and 600,000 deaths every year.[@b1-ott-8-745] CRC is a cancer mostly due to uncontrolled cell growth in the colon, rectum, or appendix. Many factors may cause CRC including smoking, obesity, alcohol, older age, high fat intake, and a lack of physical exercise.[@b2-ott-8-745] For patients in the age range of 55--64 years, flexible sigmoidoscopic screening has been used to treat CRC and could reduce its incidence and mortality by 33% and 43%, respectively.[@b3-ott-8-745] Although colonoscopic screening has become a reliable screening tool for treatment of CRC, it has the shortcomings of bleeding and perforations, as well as a tendency to cause acute diverticulitis.[@b4-ott-8-745] Therefore, the identification of reliable, accurate, and sensitive biomarkers to improve the detection of CRC is imperative.

Over the past decades, various genetic studies have been established, which are associated with the accumulated process and progress of CRC. For example, a recent study identified that the microRNA-126 that targets *CXCR4* was downregulated in CRC tissue and was involved in distant metastasis, clinical tumor--node--metastasis staging, and poor survival.[@b5-ott-8-745] Xu et al[@b6-ott-8-745] reported that downregulated microRNA-375 in tissue and plasma was matched in CRC and associated with some critical signal pathways, such as MAPK, Wnt, and TGF-beta signal pathways in the development and progression of CRC. In addition, based on gene/exon/network-level analysis tools, *ATP8B1* was found to be a novel gene associated with CRC, which changed at the cytogenetic, gene, and exon levels.[@b7-ott-8-745] After implementing a computational compilation of protein conformational changes and the probable CRC-associated phenotype, Kumar et al[@b8-ott-8-745] found that the E403K mutation in the mitotic centromere-associated kinesis protein could produce CRC-associated phenotypic affects by producing a major impact on the structural conformation of the protein. Recent evidence generated from an experimental interleukin-10- deficient mouse model using microbial genomic analysis showed that inflammation played an important role in bacteria-induced CRC.[@b9-ott-8-745] Although these expanded efforts studied the genetic bases of CRC, the molecular mechanisms of the development and progress are not fully understood.

Recently, gene expression profile data associated with CRC have been studied by many researchers. For example, Liu et al[@b10-ott-8-745] downloaded the microarray data of GSE4107 and GSE8671, screened common differentially expressed genes (DEGs) between CRC and healthy controls (HC), and performed Gene Ontology (GO) functional and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. However, they did not perform further study of DEGs, such as the construction of a protein--protein interaction (PPI) network and module analysis of the PPI network.

In the present study, using the same microarray data (GSE4107), we compared RNA expression from colonic mucosa between 12 patients with CRC and ten HC samples to identify the DEGs. In addition, we constructed the PPI network of the DEGs and performed hub gene identification and module analysis of the PPI network. The findings of this study may provide an improved understanding of and lead to an improved diagnosis of CRC.

Materials and methods
=====================

Affymetrix chip data
--------------------

The Gene Expression Omnibus (GEO) (<http://www.ncbi.nlm.nih.gov/geo/>) database at the National Center for Biotechnology Information (NCBI) is currently the largest fully public gene expression resource, which includes 214,268 samples and 4,500 platforms.[@b11-ott-8-745] The chip dataset GSE4107, which included 12 CRC patients and ten HC samples, was downloaded from GEO.[@b12-ott-8-745] The HC and CRC samples were age- (50 years or less), ethnicity- (Chinese), and tissue-matched. The RNA extracted from the colonic mucosa of the HC and CRC samples was analyzed using the GPL570 (HG-U133_Plus_2) Affymetrix Human Genome U133 Plus 2.0 Array.

Data preprocessing and analysis of DEGs
---------------------------------------

The affy package is an R package of functions and classes for the analysis of oligonucleotide arrays.[@b13-ott-8-745] Data preprocessing was performed using robust multi-array average in the affy package in R, including background adjustment, normalization, and log transformation of the values.[@b14-ott-8-745] Then, the original CEL file data were transformed to probe-level data. Further, the probe-level data were converted to gene symbols using the Perl procedure given that when several probes corresponded to one gene symbol, the gene expression value was the mean of the probes. Multiple testing was corrected using the Benjamini--Hochberg[@b15-ott-8-745] procedure to obtain the adjusted *P*-value. Then, the log2-fold change (log2FC) was calculated. Only genes with an adjusted *P*-value \<0.05 and \|log2FC\| \>1 were regarded as DEGs.

Functional and pathway enrichment analysis
------------------------------------------

As a comprehensive set of functional annotation tools, the Database for Annotation, Visualization and Integrated Discovery (DAVID) has been used for systematic and integrative analysis of large gene lists.[@b16-ott-8-745] GO terms are significantly overrepresented in a set of genes from three aspects, including the cellular component, molecular function, and biological process.[@b17-ott-8-745] In our work, the significant GO biological process terms and KEGG pathway enrichment analyses of the identified DEGs were performed using DAVID with the thresholds of *P*-value \<0.05 and enrichment gene count \>2.

PPI network construction
------------------------

The Search Tool for the Retrieval of Interacting Genes (STRING) database (<http://www.bork.embl-heidelberg.de/STRING/>)[@b18-ott-8-745] is a pre-computed global resource for the exploration and analysis of PPI information. In the present study, the STRING 9.0 online tool was used to screen the PPI of the DEGs. The DEGs with required confidence (combined score) \>0.4 were selected, and then the PPI network was constructed and visualized using Cytoscape.[@b19-ott-8-745] Given that most of the networks were scale-free, the hub genes were then selected with a connectivity degree \>10.

Module analysis of the PPI network
----------------------------------

The module analysis was performed on the PPI network using the Molecular Complex Detection (MCODE) in Cytoscape with a degree cutoff =2, node score cutoff =0.2, k-core =2, and max depth =100.[@b20-ott-8-745] Then, the significant modules with MCODE score ≥4 and node ≥6 were selected. Next, GO functional and KEGG pathway enrichment analyses of the most significant module were performed with a threshold of *P*\<0.05.

Results
=======

Identification of DEGs
----------------------

Using bioinformatics approaches, a total of 1,251 DEGs between ten HC and 12 CRC samples were identified, including 612 upregulated and 639 downregulated genes.

GO functional and pathway enrichment analysis
---------------------------------------------

Based on DAVID software, a total of 29 GO functions were enriched. Among them, the upregulated DEGs were mainly enriched in 15 GO functions and the downregulated DEGs were mainly enriched in 14 GO functions. The top five GO terms in each are shown in [Table 1](#t1-ott-8-745){ref-type="table"}. The most significant GO function in the upregulated DEGs was the regulation of cell growth, and the most significant one in the downregulated DEGs was Golgi vesicle transport.

After KEGG pathway enrichment analysis, the upregulated DEGs were mainly enriched in seven KEGG pathways including vascular smooth muscle contraction, axon guidance, and the MAPK signaling pathway. The downregulated DEGs were mainly enriched in ten pathways, such as oxidative phosphorylation and Parkinson's disease ([Table 2](#t2-ott-8-745){ref-type="table"}).

PPI network construction and hub gene identification
----------------------------------------------------

After the upregulated and downregulated DEGs were submitted into STRING, a total of 998 upregulated and 900 downregulated PPI relationships were obtained, respectively. Then, the hub genes or proteins in the networks with connectivity degree \>10 were identified ([Table 3](#t3-ott-8-745){ref-type="table"}). A total of 44 hub genes were selected from the upregulated PPI network, which included FBJ murine osteosarcoma viral oncogene homolog (*FOS*), fibronectin 1 (*FN1*), and CREB binding protein (*CREBBP*). Meanwhile, 43 hub genes, such as protein phosphatase 1, catalytic subunit, gamma isozyme (*PPP1CC*); ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 (*ATP5F1*); and cytochrome P450, family 2, subfamily B, polypeptide 6 (*CYP2B6*), were identified from the downregulated PPI network.

Module analysis
---------------

Two modules with MCODE scores ≥4 and nodes ≥6 were selected in the upregulated PPI networks: up-A (MCODE score =6.429) with 29 nodes and up-B (MCODE score =4.522) with 24 nodes ([Figure 1](#f1-ott-8-745){ref-type="fig"}). Meanwhile, there were three modules in the downregulated PPI network: d-A (MCODE score =14) with 15 nodes, d-B (MCODE score =7.75) with nine nodes, and d-C (MCODE score =7.714) with eight nodes ([Figure 2](#f2-ott-8-745){ref-type="fig"}).

The GO functional enrichment scores of modules up-A and d-A were 3.54 and 15.55, respectively. Module up-A was enriched in six functions such as behavior, taxis, and chemotaxis; module d-A was enriched in four functions such as oxidative phosphorylation and phosphorus metabolic process ([Table 4](#t4-ott-8-745){ref-type="table"}). In addition, the KEGG pathway analysis revealed that the genes in module up-A were significantly enriched in pathways including neuroactive ligand--receptor interactions and the calcium signaling pathway; the genes in module d-A were significantly enriched in oxidative phosphorylation, Parkinson's disease, Alzheimer's disease, and Huntington's disease ([Table 5](#t5-ott-8-745){ref-type="table"}).

Discussion
==========

The analysis of gene expression profiling has been widely used to reveal the abnormally expressed genes associated with CRC and has enabled the identification of targets for therapeutic strategies. In our study, the CRC mechanism was analyzed by bioinformatics, including DEGs screening, PPI network construction, hub gene identification, and module analysis of the PPI network. Based on these results, the underlying molecular mechanisms of CRC were explored on genetic and molecular levels, which provided new insights into CRC diagnosis and treatment.

After analyzing the hub genes from the upregulated PPI network, *FOS* and *FN1* were selected with the high connective degree. The FOS gene family was demonstrated to encode leucine zipper proteins and act as a regulator of cell proliferation, differentiation, and transformation.[@b21-ott-8-745] *FOS* was upregulated in the mucosa of CRC and participated in the biological processes of transcription regulation, cell growth, and inflammatory response in early-onset CRC.[@b16-ott-8-745] In addition, the overexpression of *Fra-1*, a member of the FOS family, played an essential role in tumorigenesis and was required for the motility and invasion of CRC cells through the downregulation of β1-integrin, resulting in decreased cell-substratum adhesion and cell inactivation of the Pho-ROCK pathway.[@b22-ott-8-745],[@b23-ott-8-745]

*FN1* has been found to play a major role in cell adhesion, growth, migration, differentiation, and wound healing.[@b24-ott-8-745] Increased expression of *FN1* was found in node-positive CRC and mediated migration of CRC cells in vitro.[@b25-ott-8-745] Additionally, it is well established that *FN* expression is involved in the tissue remodeling processes that are associated with CRC progression.[@b26-ott-8-745] Together with the genes that participate as mediators of cytoskeletal organization and integrin signaling, they form a pattern of colon cancer-specific changes and particularly impact cell motility.[@b27-ott-8-745] In our study, *FOS* and *FN1* were upregulated in the PPI network in CRC, suggesting that *FOS* and *FN1* may be enrolled in the process and progress of CRC. However, further studies are needed to verify our hypothesis.

Additionally, *PPP1CC* and *CYP2B6* were found as two hub genes in the downregulated PPI network. *PPP1CC* belongs to the protein phosphatase family, protein phosphatase 1 (PP1) subfamily. After analyzing the microarray data of colon cancer patients by using a Takagi-Sugeno-Kang (TSK)-type recurrent neural fuzzy network, Vineetha et al[@b28-ott-8-745] revealed that *PPP1CC* is associated with the GO term of proteolysis involved in cellular protein catabolic process and the insulin signaling pathway in CRC-related canonical pathways. In addition, PP1 was found to play an essential role in negatively regulating the extracellular signal-regulated kinase pathway in CRC cells.[@b29-ott-8-745] *CYP2B6* encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 enzymes play an important role in tumor development through their metabolism of many carcinogens.[@b30-ott-8-745] Several cytochrome P450s were found via immunohistochemistry to have increased expression in CRC and may act as independent markers of prognosis.[@b31-ott-8-745] Compounds associated with the etiology of CRC contain polycyclic aromatic hydrocarbons, in particular, heterocyclic amines, which require metabolic activation by the cytochrome P450 enzymes before exerting their genotoxic effect.[@b32-ott-8-745] In addition, many of the cytochrome P450 enzyme genes such as *CYP1A2* and *CYP1B1* play essential roles in CRC susceptibility.[@b33-ott-8-745] Taken together, these data support the hypothesis that *PPP1CC* and *CYP2B6* may act as candidate molecular markers associated with CRC.

In the current study, our data were downloaded from the gene expression profile dataset GSE4107, which has been reported by Hong et al.[@b12-ott-8-745] As in Hong et al's study, we also analyzed the DEGs between CRC samples and HC and performed GO functional and pathway enrichment analyses to explore the potential molecular mechanism of CRC. However, there are still some discrepancies. Based on Hong et al's study, further studies using bioinformatics were performed, such as the construction of a PPI network, hub gene analysis, and module analysis of the PPI network. Then, 998 upregulated and 900 downregulated PPI relationships were obtained followed by the identification of 44 hub genes from the upregulated PPI network and 43 from the downregulated PPI network. Additionally, two modules (up-A and up-B) in the upregulated PPI network and three modules (d-A, d-B, and d-C) in the downregulated PPI network were identified.

However, there are some limitations in our study. First, the small amount of data used in the current study were downloaded from the GEO database, not generated by us. Because GEO is a huge data repository, a meta-analysis of the relevant datasets of CRC may be performed in future studies. Second, the results were web-based and were not verified by biological experiments. Thus, further experimental studies based on our findings are still needed.

In summary, our study provides a comprehensive bioinformatics analysis of DEGs which may be involved in the progression and development of CRC. The findings of this study may provide a basis for understanding the underlying molecular mechanisms of CRC. In addition, DEGs such as *FOS*, *FNI*, *PPP1CC*, and *CYP2B6* may be used as potential therapeutic targets for CRC. However, further studies are necessary for improving the diagnosis and treatment of CRC through regulating DEGs.
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###### 

GO functional enrichment analysis of up- and downregulated DEGs (top five in each)

  Category        Term         Description                             Count   *P*-value   Size
  --------------- ------------ --------------------------------------- ------- ----------- ------
  Upregulated                                                                              
   BP             GO:0001558   Regulation of cell growth               20      3.38E-04    193
   BP             GO:0016477   Cell migration                          24      6.74E-04    270
   BP             GO:0044057   Regulation of system process            26      7.02E-04    305
   BP             GO:0040008   Regulation of growth                    27      1.31E-03    336
   BP             GO:0008361   Regulation of cell size                 19      1.81E-03    205
  Downregulated                                                                            
   BP             GO:0048193   Golgi vesicle transport                 16      3.24E-05    131
   BP             GO:0015031   Protein transport                       45      2.18E-04    752
   BP             GO:0045184   Establishment of protein localization   45      2.63E-04    759
   BP             GO:0046907   Intracellular transport                 40      3.21E-04    652
   BP             GO:0070727   Cellular macromolecule localization     28      6.28E-04    409

**Notes:** Category: GO function. Count: the number of DEGs. The *P*-value was adjusted using the Benjamini--Hochberg method. Size: the total number of genes in the GO BP.

**Abbreviations:** BP, biological process; DEGs, differentially expressed genes; GO, Gene Ontology.

###### 

The enriched KEGG pathway of DEGs

  Category        Term       Description                                   Count   *P*-value   Size
  --------------- ---------- --------------------------------------------- ------- ----------- ------
  Upregulated                                                                                  
   KEGG           hsa04270   Vascular smooth muscle contraction            10      3.45E-02    111
   KEGG           hsa04360   Axon guidance                                 11      3.50E-02    129
   KEGG           hsa04010   MAPK signaling pathway                        18      3.93E-02    266
  Downregulated                                                                                
   KEGG           hsa00190   Oxidative phosphorylation                     18      6.70E-06    119
   KEGG           hsa05012   Parkinson's disease                           17      1.59E-05    114
   KEGG           hsa05010   Alzheimer's disease                           19      7.04E-05    156
   KEGG           hsa05016   Huntington's disease                          20      7.42E-05    171
   KEGG           hsa00970   Aminoacyl-tRNA biosynthesis                   8       1.33E-03    41
   KEGG           hsa00830   Retinol metabolism                            8       3.83E-03    49
   KEGG           hsa00860   Porphyrin and chlorophyll metabolism          6       7.30E-03    30
   KEGG           hsa00280   Valine, leucine, and isoleucine degradation   6       3.49E-02    44
   KEGG           hsa04664   Fc epsilon RI signaling pathway               8       3.80E-02    76
   KEGG           hsa04666   Fc gamma R-mediated phagocytosis              9       4.13E-02    94

**Notes:** Count: the number of DEGs. Size: the total number of genes in the pathway.

**Abbreviations:** DEGs, differentially expressed genes; KEGG, Kyoto Encyclopedia of Genes and Genomes.

###### 

The hub proteins in the upregulated and downregulated protein--protein interaction network (top 20 in each)

  ID              Degree   ID        Degree   ID       Degree   ID        Degree
  --------------- -------- --------- -------- -------- -------- --------- --------
  Upregulated                                                             
   FOS            41       IGF1      25       DES      19       CALD1     16
   FN1            34       CD44      25       EGR1     19       CAV1      16
   CREBBP         33       COL14A1   21       TAGLN    17       RET       16
   ESR1           32       MGP       20       ATF3     17       ACTA2     15
   DCN            26       GSK3B     20       MYH11    16       RUNX1T1   15
  Downregulated                                                           
   PPP1CC         24       HDAC1     22       SOD2     20       ATP5O     18
   ATP5F1         24       GAPDH     22       PPARA    19       RAC1      17
   CYP2B6         23       MAPK1     22       UQCRH    19       COX4I1    17
   ATP5J          23       ATP5L     21       HINT1    18       C14orf2   16
   DHX15          23       UQCR11    20       ATP5G3   18       COX7C     15

**Note:** Degree: the connectivity of the protein.

###### 

The GO functional enrichment analysis of DEGs in the up-A and d-A modules with the threshold of *P*\<0.05

  Category      Term                     Description                    Count   *P*-value   Size
  ------------- ------------------------ ------------------------------ ------- ----------- ------
  Module up-A   Enrichment score:3.54                                                       
   BP           GO:0007610               Behavior                       11      2.57E-08    458
   BP           GO:0042330               Taxis                          5       3.45E-04    154
   BP           GO:0006935               Chemotaxis                     5       3.45E-04    154
   BP           GO:0006952               Defense response               7       1.53E-03    587
   BP           GO:0007626               Locomotory behavior            5       2.56E-03    264
   BP           GO:0006955               Immune response                5       4.88E-02    632
  Module d-A    Enrichment score:15.55                                                      
   BP           GO:0006119               Oxidative phosphorylation      9       2.53E-15    91
   BP           GO:0016310               Phosphorylation                9       8.11E-08    781
   BP           GO:0006793               Phosphorus metabolic process   9       3.72E-07    950
   BP           GO:0006796               Phosphate metabolic process    9       3.72E-07    950

**Notes:** Category: GO function. Count: the number of DEGs. Enrichment score: the score of GO enrichment. Size: the total number of genes in the GO BP.

**Abbreviations:** BP, biological process; DEGs, differentially expressed genes; GO, Gene Ontology.

###### 

The KEGG pathway enrichment analysis of DEGs in the up-A and d-A modules with the threshold of *P*\<0.05

  Category      Term       Description                                Count   *P*-value   Size
  ------------- ---------- ------------------------------------------ ------- ----------- ------
  Module up-A                                                                             
   Pathway      hsa04080   Neuroactive ligand--receptor interaction   7       1.16E-04    254
   Pathway      hsa04020   Calcium signaling pathway                  6       2.07E-04    175
  Module d-A                                                                              
   Pathway      hsa00190   Oxidative phosphorylation                  13      3.75E-20    119
   Pathway      hsa05012   Parkinson's disease                        12      1.17E-17    114
   Pathway      hsa05010   Alzheimer's disease                        12      4.20E-16    156
   Pathway      hsa05016   Huntington's disease                       12      1.19E-15    171

**Notes:** Category: KEGG pathway. Count: the number of DEGs. Size: the total number of genes in the pathway.

**Abbreviations:** DEGs, differentially expressed genes; KEGG, Kyoto Encyclopedia of Genes and Genomes.

[^1]: These authors contributed equally to this work
